Skip to content

Acute Response to Cigarette and E-cigarette Smoking Assesed in Exhaled Breath Condensate in Healthy Smokers of Traditional and E-cigarettes

The Comparison of Biomarkers of Acute Response to Cigarette Smoking and E-cigarettes Smoking Assesed in Exhaled Breath Condensate in Healthy Smokers of Traditional and Electronical Cigarettes.

Status
UNKNOWN
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT03153228
Enrollment
87
Registered
2017-05-15
Start date
2017-05-08
Completion date
2018-10-31
Last updated
2017-05-15

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

E-cigarettes

Keywords

E-cigarettes

Brief summary

Electronical cigarettes, also known as e-cigarettes are a new phenomenon, which steadily wins more aprobation among smokers. However, there exists no much data concerning the effects of acute exposure to electronic cigarettes vapour on the respiratory system. The aim of the present study is to evaluate and compare the acute response to electronic and traditional cigarettes in healthy smokers.

Detailed description

The aim of the study is: * to evaluate the acute response to traditional cigarettes on the respiratory system * to evaluate the acute response to electronic cigarettes on the respiratory system * to assess the relationship between the type of smoked cigarettes (traditional vs. electronic) and concentration of markers of airway inflammation released in healthy smokers Material and methods: * 29 healthy smokers of traditional cigarettes * 29 healthy smokers of electronic cigarettes * 29 healthy, nonsmoking volunteers After 8 hours of smoking abstinence: * the spirometry test * the first collection of the exhaled breath condensate (EBC I) * smoking a traditional / electronic cigarette * the second collection of the exhaled breath condensate (EBC II) - one hour after smoking * the third collection of the exhaled breath condensate (EBC III) - six hours after smoking * the measurement of biomarkers of oxidative stress in the EBC (isoprostane-8, malondialdehyde MDA, IL-8) and pH of the EBC

Interventions

None listed

Sponsors

Medical University of Warsaw
Lead SponsorOTHER

Study design

Observational model
CASE_CONTROL
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to 90 Years
Healthy volunteers
Yes

Inclusion criteria

* healthy smokers of traditional cigarettes - min. 1 packyear * healthy smokers of e-cigarettes - min. 1 year of smoking history * control group - healthy nonsmoking volunteers without any history of lung disease

Exclusion criteria

* age below 18 years * inhaled corticosteroid therapy at least 6 weeks prior to study enrollment * any co-morbidities * respiratory infections at least 6 weeks prior to study enrollment

Design outcomes

Primary

MeasureTime frameDescription
Inflammatory markers in exhaled breath condensateApproximately 1-2 months after completion of study procedures in all patientsInflammatory markers in exhaled breath condensate in healthy subjects, smokers of traditional cigarettes and e-cigarette smokers

Countries

Poland

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026